Mahesh Kulharia
Mahesh Kulharia
Central University of Punjab, Bathinda
No verified email
Cited by
Cited by
Identification and specificity profiling of protein prenyltransferase inhibitors using new fluorescent phosphoisoprenoids
B Dursina, R Reents, C Delon, Y Wu, M Kulharia, M Thutewohl, ...
Journal of the American Chemical Society 128 (9), 2822-2835, 2006
InCa-SiteFinder: a method for structure-based prediction of inositol and carbohydrate binding sites on proteins
M Kulharia, SJ Bridgett, RS Goody, RM Jackson
Journal of Molecular Graphics and Modelling 28 (3), 297-303, 2009
Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques
C Mencarelli, GH Bode, M Losen, M Kulharia, PC Molenaar, R Veerhuis, ...
Journal of Biological Chemistry 287 (18), 14897-14911, 2012
Rational design of small molecules targeting the C2 domain of coagulation factor VIII
GAF Nicolaes, M Kulharia, J Voorberg, PH Kaijen, A Wroblewska, ...
Blood, The Journal of the American Society of Hematology 123 (1), 113-120, 2014
Information Theory-Based Scoring Function for the Structure-Based Prediction of Protein− Ligand Binding Affinity
M Kulharia, RS Goody, RM Jackson
Journal of chemical information and modeling 48 (10), 1990-1998, 2008
Homology modeling and structural validation of tissue factor pathway inhibitor
P Agrawal, Z Thakur, M Kulharia
Bioinformation 9 (16), 808, 2013
Understanding human thiol dioxygenase enzymes: structure to function, and biology to pathology
B Sarkar, M Kulharia, AK Mantha
International Journal of Experimental Pathology 98 (2), 52-66, 2017
Rational design of drug-like compounds targeting Mycobacterium marinum MelF protein
R Dharra, S Talwar, Y Singh, R Gupta, JD Cirillo, AK Pandey, M Kulharia, ...
PloS one 12 (9), e0183060, 2017
Proteomics & metabolomics: Mapping biochemical regulations
A Gahlaut, M Dahiya, A Gothwal, M Kulharia, AK Chhillar, V Hooda, ...
Drug Invention Today 5 (4), 321-326, 2013
Antioxidant, xanthine oxidase and monoamine oxidase inhibitory potential of coumarins: a review
P Dhiman, N Malik, A Khatkar, M Kulharia
Current Organic Chemistry 21 (4), 294-304, 2017
A study of mechanistic mapping of novel SNPs to male breast cancer
RP Kaur, V Kumar, G Shafi, R Vashistha, M Kulharia, A Munshi
Medical Oncology 36 (8), 70, 2019
Comparative evaluation of commercially available homology modelling tools: a structural bioinformatics perspective
S Dahiya, A Gahlaut, M Kulharia
Drug Invention Today 5 (3), 207-211, 2013
PPInS: a repository of protein-protein interaction sitesbase
V Kumar, S Mahato, A Munshi, M Kulharia
Scientific reports 8 (1), 1-9, 2018
Evaluation of in silico designed inhibitors targeting MelF (Rv1936) against Mycobacterium marinum within macrophages
R Dharra, VS Radhakrishnan, T Prasad, Z Thakur, JD Cirillo, A Sheoran, ...
Scientific reports 9 (1), 1-11, 2019
Could mycobacterial MelF protein (Rv1936) be used as a potential drug target?
PK Mehta, R Dharra, M Kulharia
Future microbiology 13 (11), 1211-1214, 2018
Insights from the Molecular dynamics simulation of BcsD Subunit from K. xylinus
S Kaur, M Kulharia
Bioinformation 13 (11), 376, 2017
Insights from the analysis of alginate lyase protein model from Pseudomonas fluorescens towards the understanding of mucoid biofilm disruption
G Singh, M Kulharia
Bioinformation 13 (9), 318, 2017
A Feature Matching Approach for Pharmacophore Modelling: Concepts and Applications
S Mahato, M Kulharia
Scholars Press, 2016
Proteomics & metabolomics: Mapping biochemical regulations
M Kulharia, AK Chhillar, V Hooda, R Dabur
Targeting of the tenase complex by rational design of factor VIII-membrane interaction inhibitors: P-MO-601
G Nicolaes, M Kulharia, O Sperandio, J Voorberg, S Wielders, ...
Journal of Thrombosis and Haemostasis 9, 2011
The system can't perform the operation now. Try again later.
Articles 1–20